Patients | Healthy subjects | ||||
---|---|---|---|---|---|
On admission (T0) | After recovery (T4) | ||||
No GC | GC | No GC | GC | ||
CD3+ T lymphocytes | 2.3 (2.6)*** | 3.6 (4.9)*** | 11 (4.6) | 9.4 (6.7)* | 18 (7.9) |
CD4+ T lymphocytes | 1.1 (1.1)*** | 2.3 (4.3)*** | 5.1 (1.4) | 4.3 (3.9)* | 10 (4.4) |
CD8+ T Lymphocytes | 1.0 (1.1)*** | 1.3 (1.8)*** | 4.1 (2.7) | 4.4 (5.6) | 6.5 (3.2) |
B lymphocytes | 1.6 (2.7) | 1.0 (1.7) | 1.9 (2.0) | 0.6 (0.7)* | 2.0 (1.3) |
NK cells | 0.8 (1.4) | 0.8 (0.7) | 3.6 (2.3) | 0.8 (0.8) | 2.1 (2.0) |
Monocytes | 5.7 (3.5) | 1.9 (1.8)***a | 3.0 (2.1) | 3.8 (2.5) | 5.3 (2.5) |
Neutrophils | 145 (63)*** | 76 (66)a | 28 (8.3) | 41 (29) | 51 (23) |
Eosinophils | 0.9 (1.2) | 0.8 (2.2)* | 1.8 (0.4) | 2.0 (1.4) | 2.9 (2.6) |